Endometriosis
Biopharmaceutical company announces positive endometriosis trial results
Published in Women's Health Weekly, March 31st, 2005
The trial was designed to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of two dose levels of NBI-56418 given once daily for 6 weeks in 60 healthy premenopausal women. The study demonstrated that NBI-56418 was safe and well tolerated. NBI-56418 demonstrated a dose-dependent suppression of estradiol that was observed throughout the duration of dosing.
The study was a double-blind, placebo-controlled trial involving...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Non-invasive and invasive breast cancers share same BRCA1/2 mutations - Cervical Cancer
Cost effectiveness of four management strategies for ASCUS compared - Myocardial Infarction
Women less likely than men to get quality heart attack care - Obstetrics
Smoking while pregnant may increase chromosomal abnormalities in fetal cells - Stroke
Women's Health Study: Low-dose aspirin lowers stroke risk among older women - Abortion
Women at risk of more than one termination of pregnancy are older, multiparous - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
